The immunosuppressive peptide of HIV-1 inhibits T and B lymphocyte stimulation

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 5, 1996, Pages 442-150

  Denner, Joachim ^a   Persin, Christoph ^a   Vogel, Thorsten ^a   Haustein, Dieter ^a   Norley, Stephen ^a   Kurth, Reinhard ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

HIV 1; Immunosuppression; Peptides; Transmembrane glycoprotein

Indexed keywords

CARRIER PROTEIN; MEMBRANE PROTEIN; PEPTIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE ACTIVATION; MITOGENESIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS INHIBITION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0029789613     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199608150-00002     Document Type: Article

References (38)

1. Lane HC, Fauci AS. Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol 1985;3:477-500.
2. Pahwa S, Pahwa R, Saxinger C, Gallo RC, Good RA. Influence of the human T-lymphotropic virus/lymphoadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci USA 1985;82:8198-202.
3. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-8.
4. Amman AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 1984;251:1447-9.
5. Denner J, Norley S, Kurth R. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. JAIDS 1994;8:1063-72.
6. Denner J, Norley SG, Cichutek K, Ennen J, Kurth R: Factors determining the pathogenicity of immunodeficiency viruses. AIDS-Forschung (AIFO) 1993;8:301-6.
7. Cianciolo GJ, Bogerd H, Snyderman R. Human retrovirus-related peptides inhibit T lymphocyte proliferation. Immunol Lett 1988;19:7-14.
8. Ruegg CL, Monell CR, Strand M. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J Virol 1989; 63:3257-60.
9. Hebebrand LC, Olsen RG, Mathes LE, Nicols WS. Inhibition of human lymphocyte mitogen and antigen response by a 15,000 dalton protein from feline leukemia virus. Cancer Res 1979;39:443-7.
10. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985; 230:453-5.
11. Wegemer D, Kabat KG, Kloetzer WS. Biological activities of a synthetic peptide composed of two unlinked domains from a retroviral transmembrane protein sequence. J Virol 1990;64:1429-36.
12. Harrell RA, Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R. Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of animal and human retroviruses. J Immunol 1986; 136:3517-20.
13. Harris DT, Cianciolo GJ, Snyderman R, Argov S, Koren HS. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E. J Immunol 1987;138:889-94.
14. Mitani M, Cianciolo GJ, Snyderman R, Yasuda M, Good RA, Day NK. Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses. Proc Natl Acad Sci USA 1987;84:237-40.
15. Lafrado LJ, Lewis MG, Mathes LE, Olsen RG. Suppression of an in vitro neutrophil function by feline leukemia virus (FeLV) and purified FeLV-p15E. J Gen Virol 1987;68:507-13.
16. Wellman ML, Kociva GJ, Lewis MG, Mathes LE, Olsen RG. Inhibition of erythroid colony-forming cells by a Mr 15,000 protein of feline leukemia virus. Cancer Res 1984;44: 1527-9.
17. Mathes LE, Olsen RG, Hebebrand LC, et al. Immunosuppressive properties of a virion poly peptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res 1979;39: 950-5.
18. Cianciolo GJ, Mathews TJ, Bolognesi DP, Snyderman R. Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. J Immunol 1980;124:2900-5.
19. Ratner L, Haseltine W, Patarca WR, et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985; 313:277-84.
20. Kraus G, Werner A, Baier M, et al. Isolation of human immunodeficiency virus-related simian immunodeficiency viruses from African green monkeys. Proc Natl Acad Sci USA 1989;86:2892-6.
21. Norley SG, Kraus G, Ennen J, Bonilla J, König H, Kurth R. Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys. Proc Natl Acad Sci USA 1990;87:9067-71.
22. Stobo JD. Phytohemagglutin and concanavalin A: probes for murine T cell activation and differentiation. Transplant Rev 1972;11:60-86.
23. Denner J. Immunosuppression by oncogenic retroviridae. In: Zschiesche W, ed. Modulation of the immune responsiveness by infectious agents. Jena: Fischer Verlag, 1987: 114-201.
24. Mann DL, Lasane F, Popovic M, et al. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol 1987;138:2640-4.
25. Shalaby MR, Krowka JF, Gregory TJ, et al. The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. Cell Immunol 1987;110:140-8.
26. Maddon PJ, Dalgleish AG, McDoughal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47:333-48.
27. Edelman AS, Zolla-Pazner S. Response of mononuclear cells from HIV-infected patients to B-cell mitogens: correlation with immunological and clinical features of disease progression. AIDS 1990;4:859-64.
28. Hofmann B, Lindhardt BO, Gerstoft J, et al. Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J 1987;295:293-6.
29. Kornfeld H, Cruikshank WW, Pyle SW, Berman JS, Center DM. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 1988;335:445-8.
30. Denner J, Vogel T, Norley S, Ennen J, Kurth R. The immunosuppressive (ISU-) peptide of HIV-1: binding to lymphocyte surface proteins. J Cancer Res Clin Oncol 1993;119 (suppl 1):28.
31. Denner J, Wunderlich V, Sydow G. Suppression of human lymphocyte mitogen response by retroviruses of type D. I. Action of highly purified and disrupted virus. Arch Virol 1985;86:177-86.
32. Denner J, Indzhiia L, Wunderlich V, Sydow G, Bierwolf D, Lapin BA. Suppression of human lymphocyte mitogen response by retroviruses of type D. II. Non-activity of Mason-Pfizer virus versus activity of human cell line derived virus PMFV. Arch Virol 1985;86:187-96.
33. Ruegg CL, Monell CR, Strand M. Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. J Virol 1989;63: 3250-6.
34. Oh S-K, Cerda S, Lee B-G, Blanchard GC, Walker JE, Hartshorn K. Partial purification of an immunosuppressive factor in AIDS sera. AIDS Res Hum Retrovirus 1993;9:365-73.
35. Tas M, Drexhage HA, Goudsmit J. A monocyte chemotaxis inhibiting factor in serum of HIV infected men shares epitopes with the HIV transmembrane protein gp41. Clin Exp Immunol 1988;71:13-8.
36. Henderson LA, Qureshi MN. A peptide inhibitor of human immunodeficiency virus infection binds to novel cell surface polypeptides. J Biol Chem 1993;268:16291-7.
37. Wild C, Oas T, McDanal C, Bolognesi D, Matthews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc Natl Acad Sci USA 1992;89:10537-41.
38. Denner J, Vogel T, Norley S, Hoffmann A, Kurth R. The immunosuppressive (ISU-) peptide of HIV-1: binding proteins on lymphocytes detected by different methods. J Cancer Res Clin Oncol 1995;121(suppl 1):34.